Lilly launches Tanstrive (Selpercatinib), a RET inhibitor to treat advanced cancers with RET gene… EP News Bureau Jun 25, 2026 Available in India in 40 mg, 80 mg, 120 mg and 160 mg tablet strengths; administered orally twice daily
Servier India launches biomarker testing initiative for AML and Cholangiocarcinoma patients EP News Bureau Nov 11, 2025 The programme is introduced in collaboration with MedGenome and Strand Life Sciences to expand access to molecular testing across…
Queens University Belfast study reveals strong economic case for precision oncology medicine EP News Bureau Sep 26, 2023 The study also showed that by using the “CDx guided approach”, which uses a companion diagnostic to identify patients who are most…
